20032020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020
2019

Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients.

Reale, M. L., Chiari, R., Tiseo, M., Vitiello, F., Barbieri, F., Cortinovis, D., Ceresoli, G. L., Finocchiaro, G., Romano, G. D., Piovano, P. L., Del Conte, A., Borra, G., Verderame, F., Scotti, V., Nonnis, D., Galetta, D., Sergi, C., Migliorino, M. R., Tonini, G., Cecere, F. & 11 others, Berardi, R., Pino, M. S., Martelli, O., Gelibter, A., Carta, A., Vattemi, E., Pagano, M., Zullo, A., Ferrari, S., Rossi, A. & Novello, S., Dec 16 2019, In : Lung Cancer.

Research output: Contribution to journalArticle

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

Passiglia, F., Cappuzzo, F., Alabiso, O., Bettini, A. C., Bidoli, P., Chiari, R., Defferrari, C., Delmonte, A., Finocchiaro, G., Francini, G., Gelsomino, F., Giannarelli, D., Giordano, M., Illiano, A., Livi, L., Martelli, O., Natoli, C., Puppo, G., Ricevuto, E., Roca, E. & 2 others, Turci, D. & Galetta, D., 2019, In : British Journal of Cancer. 120, 1, p. 57-62 6 p.

Research output: Contribution to journalArticle

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

Passiglia, F., Cappuzzo, F., Alabiso, O., Bettini, A. C., Bidoli, P., Chiari, R., Defferrari, C., Delmonte, A., Finocchiaro, G., Francini, G., Gelsomino, F., Giannarelli, D., Giordano, M., Illiano, A., Livi, L., Martelli, O., Natoli, C., Puppo, G., Ricevuto, E., Roca, E. & 2 others, Turci, D. & Galetta, D., Jan 8 2019, In : British Journal of Cancer. 120, 1, p. 57-62 6 p.

Research output: Contribution to journalArticle

Liquid biopsy testing can improve selection of advanced non-small-cell lung cancer patients to rechallenge with gefitinib

Abate, R. E., Pasquale, R., Sacco, A., Piccirillo, M. C., Morabito, A., Bidoli, P., Finocchiaro, G., Chiari, R., Foltran, L., Buosi, R., Tiseo, M., Giannetta, L., Battiloro, C., Fasola, G., Romano, G., Ciuffreda, L., Frassoldati, A., Marinis, F. D., Cappuzzo, F. & Normanno, N., Oct 2019, In : Cancers. 11, 10, 1431.

Research output: Contribution to journalArticle

Open Access

Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib

Esposito Abate, R., Pasquale, R., Sacco, A., Piccirillo, M. C., Morabito, A., Bidoli, P., Finocchiaro, G., Chiari, R., Foltran, L., Buosi, R., Tiseo, M., Giannetta, L., Battiloro, C., Fasola, G., Romano, G., Ciuffreda, L., Frassoldati, A., de Marinis, F., Cappuzzo, F. & Normanno, N., Sep 25 2019, In : Cancers. 11, 10, 10 p., 1431.

Research output: Contribution to journalArticle

Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer

Rossi, S., Finocchiaro, G., Noia, V. D., Bonomi, M., Cerchiaro, E., Rose, F. D., Franceschini, D., Navarria, P., Ceresoli, G. L., Beretta, G. D., D'Argento, E., Scorsetti, M., Santoro, A. & Toschi, L., Nov 2019, In : Future oncology (London, England). 15, 33, p. 3775-3782 8 p.

Research output: Contribution to journalArticle

2018

Checkpoint inhibitors: 'Raising the bar' also in brain metastases from non-small-cell lung cancer?

Rossi, S., Finocchiaro, G., Marchetti, S., Toschi, L. & Santoro, A., Apr 1 2018, In : Immunotherapy. 10, 5, p. 403-410 8 p.

Research output: Contribution to journalReview article

Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non–Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors

Rossi, S., Toschi, L., Finocchiaro, G., Di Noia, V., Bonomi, M., Cerchiaro, E., Ceresoli, G. L., Beretta, G. D., D'Argento, E. & Santoro, A., Jan 1 2018, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

2017

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study

Brandes, A. A., Finocchiaro, G., Zagonel, V., Reni, M., Fabi, A., Caserta, C., Tosoni, A., Eoli, M., Lombardi, G., Clavarezza, M., Paccapelo, A., Bartolini, S., Cirillo, L., Agati, R. & Franceschi, E., 2017, In : Oncotarget. 8, 33, p. 55575-55581 7 p.

Research output: Contribution to journalArticle

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study

Brandes, AA., Finocchiaro, G., Zagonel, V., Reni, M., Fabi, A., Caserta, C., Tosoni, A., Eoli, M., Lombardi, G., Clavarezza, M., Paccapelo, A., Bartolini, S., Cirillo, L., Agati, R. & Franceschi, E., 2017, In : Oncotarget. 8, 33, p. 55575-55581 7 p.

Research output: Contribution to journalArticle

2016

Efficacy and safety data from patients with advanced squamous NSCLC and brain metastases participating in the nivolumab Expanded Access Programme (EAP) in Italy

Bidoli, P., Chiari, R., Catino, A., Grossi, F., Noberasco, C., Gelsomino, F., Gilli, M., Proto, C., Parra, H. J. S., Migliorino, M. R., Bonomi, L., Tassinari, D., Frassoldati, A., Albanese, V., Fadda, G. M., Cognetti, F., de galitiis, F., Finocchiaro, G. & Delmonte, A., Oct 1 2016, In : Annals of Oncology. 27, p. vi425

Research output: Contribution to journalArticle

Open Access

Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer

Cappuzzo, F., Morabito, A., Normanno, N., Bidoli, P., Del Conte, A., Giannetta, L., Montanino, A., Mazzoni, F., Buosi, R., Burgio, M. A., Cerea, G., Chiari, R., Cortinovis, D. L., Finocchiaro, G., Foltran, L., Migliorino, M. R., Tiseo, M., Ferrari, S. & De Marinis, F., Sep 1 2016, In : Lung Cancer. 99, p. 31-37 7 p.

Research output: Contribution to journalArticle

Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer

Cappuzzo, F., Morabito, A., Normanno, N., Bidoli, P., Del Conte, A., Giannetta, L., Montanino, A., Mazzoni, F., Buosi, R., Burgio, M. A., Cerea, G., Chiari, R., Cortinovis, D. L., Finocchiaro, G., Foltran, L., Migliorino, M. R., Tiseo, M., Ferrari, S. & De Marinis, F., Sep 1 2016, In : Lung Cancer. 99, p. 31-37 7 p.

Research output: Contribution to journalArticle

Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer

Cappuzzo, F., Morabito, A., Normanno, N., Bidoli, P., Del Conte, A., Giannetta, L., Montanino, A., Mazzoni, F., Buosi, R., Burgio, M. A., Cerea, G., Chiari, R., Cortinovis, D. L., Finocchiaro, G., Foltran, L., Migliorino, M. R., Tiseo, M., Ferrari, S. & De Marinis, F., Sep 1 2016, In : Lung Cancer. 99, p. 31-37 7 p.

Research output: Contribution to journalArticle

2015

Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography

Infante, M., Cavuto, S., Lutman, F. R. O., Passera, E., Chiarenza, M., Chiesa, G., Brambilla, G., Angeli, E., Aranzulla, G., Chiti, A., Scorsetti, M., Navarria, P., Cavina, R., Ciccarelli, M., Roncalli, M., Destro, A., Bottoni, E., Voulaz, E., Errico, V., Ferraroli, G. & 5 others, Finocchiaro, G., Toschi, L., Santoro, A., Alloisio, M. & DANTE Study Group, May 15 2015, In : American Journal of Respiratory and Critical Care Medicine. 191, 10, p. 1166-1175 10 p.

Research output: Contribution to journalArticle

Phase II study of afatinib, an irreversible ERBB family blocker, in EGFR FISH-positive non-small-cell lung cancer

Cappuzzo, F., Finocchiaro, G., Grossi, F., Bidoli, P., Favaretto, A., Marchetti, A., Valente, M. L., Cseh, A., Clementi, L., Massey, D. & Santoro, A., Apr 30 2015, In : Journal of Thoracic Oncology. 10, 4, p. 665-672 8 p.

Research output: Contribution to journalArticle

When is surgery indicated for small-cell lung cancer?

Veronesi, G., Bottoni, E., Finocchiaro, G. & Alloisio, M., Dec 1 2015, In : Lung Cancer. 90, 3, p. 582-589 8 p.

Research output: Contribution to journalArticle

2014

Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease

Toschi, L., Finocchiaro, G., Nguyen, T. T., Skokan, M. C., Giordano, L., Gianoncelli, L., Perrino, M., Siracusano, L., Tommaso, L. D., Infante, M., Alloisio, M., Roncalli, M., Scorsetti, M., Janne, P. A., Santoro, A. & Varella-Garcia, M., Apr 15 2014, In : PLoS One. 9, 4, e95303.

Research output: Contribution to journalArticle

Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease

Toschi, L., Finocchiaro, G., Nguyen, T. T., Skokan, M. C., Giordano, L., Gianoncelli, L., Perrino, M., Siracusano, L., Di Tommaso, L., Infante, M., Alloisio, M., Roncalli, M., Scorsetti, M., Jänne, P. A., Santoro, A. & Varella-Garcia, M., Apr 1 2014, In : PLoS One. 9, 4, e0095303.

Research output: Contribution to journalArticle

2010

Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy

Santoro, A., Rimassa, L., Sobrero, A. F., Citterio, G., Sclafani, F., Carnaghi, C., Pessino, A., Caprioni, F., Andretta, V., Tronconi, M. C., Finocchiaro, G., Rossoni, G., Zanoni, A., Miggiano, C., Rizzardi, G. P., Traversari, C., Caligaris-Cappio, F., Lambiase, A. & Bordignon, C., Oct 2010, In : European Journal of Cancer. 46, 15, p. 2746-2752 7 p.

Research output: Contribution to journalArticle

2009

Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: An important role for mutations in minor clones

Marchetti, A., Milella, M., Felicioni, L., Cappuzzo, F., Irtelli, L., Del Grammastro, M., Sciarrotta, M., Malatesta, S., Nuzzo, C., Finocchiaro, G., Perrucci, B., Carlone, D., Gelibter, A. J., Ceribelli, A., Mezzetti, A., Iacobelli, S., Cognetti, F. & Buttitta, F., Oct 2009, In : Neoplasia (United States). 11, 10, p. 1084-1092 9 p.

Research output: Contribution to journalArticle

Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients

Cappuzzo, F., Marchetti, A., Skokan, M., Rossi, E., Gajapathy, S., Felicioni, L., Grammastro, M. D., Sciarrotta, M. G., Buttitta, F., Incarbone, M., Toschi, L., Finocchiaro, G., Destro, A., Terracciano, L., Roncalli, M., Alloisio, M., Santoro, A. & Varella-Garcia, M., Apr 1 2009, In : Journal of Clinical Oncology. 27, 10, p. 1667-1674 8 p.

Research output: Contribution to journalArticle

Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients

Cappuzzo, F., Tallini, G., Finocchiaro, G., Wilson, R. S., Ligorio, C., Giordano, L., Toschi, L., Incarbone, M., Cavina, R., Terracciano, L., Roncalli, M., Alloisio, M., Varella-Garcia, M., Franklin, W. A. & Santoro, A., Sep 18 2009, In : Annals of Oncology. 21, 3, p. 562-567 6 p., mdp357.

Research output: Contribution to journalArticle

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients

Cappuzzo, F., Jänne, P. A., Skokan, M., Finocchiaro, G., Rossi, E., Ligorio, C., Zucali, P. A., Terracciano, L., Toschi, L., Roncalli, M., Destro, A., Incarbone, M., Alloisio, M., Santoro, A. & Varella-Garcia, M., 2009, In : Annals of Oncology. 20, 2, p. 298-304 7 p.

Research output: Contribution to journalArticle

2008

EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients

Cappuzzo, F., Finocchiaro, G., Rossi, E., Jänne, P. A., Carnaghi, C., Calandri, C., Bencardino, K., Ligorio, C., Ciardiello, F., Pressiani, T., Destro, A., Roncalli, M., Crino, L., Franklin, W. A., Santoro, A. & Varella-Garcia, M., Apr 2008, In : Annals of Oncology. 19, 4, p. 717-723 7 p.

Research output: Contribution to journalArticle

EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients: How do we interpret the clinical and biomarker data?

Califano, R., Blackhall, F. H., Finocchiaro, G., Toschi, L., Thatcher, N., Cappuzzo, F. & Crinò, L., Jul 2008, In : Targeted Oncology. 3, 3, p. 173-186 14 p.

Research output: Contribution to journalArticle

Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients

Cappuzzo, F., Varella-Garcia, M., Finocchiaro, G., Skokan, M., Gajapathy, S., Carnaghi, C., Rimassa, L., Rossi, E., Ligorio, C., Di Tommaso, L., Holmes, A. J., Toschi, L., Tallini, G., Destro, A., Roncalli, M., Santoro, A. & Jänne, P. A., Jul 8 2008, In : British Journal of Cancer. 99, 1, p. 83-89 7 p.

Research output: Contribution to journalArticle

2007

EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)

Cappuzzo, F., Ligorio, C., Toschi, L., Rossi, E., Trisolini, R., Paioli, D., Magrini, E., Finocchiaro, G., Bartolini, S., Cancellieri, A., Hirsch, F. R., Crino, L. & Varella-Garcia, M., May 2007, In : Journal of Thoracic Oncology. 2, 5, p. 423-429 7 p.

Research output: Contribution to journalArticle

Erratum: EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (Journal of Thoracic Oncology (2007) 2, 5, (423-429))

Cappuzzo, F., Ligorio, C., Toschi, L., Rossi, E., Trisolini, R., Paioli, D., Magrini, E., Finocchiaro, G., Bartolini, S., Cancellieri, A., Hirsch, F. R., Crino, L. & Varella-Garcia, M., Jul 2007, In : Journal of Thoracic Oncology. 2, 7, p. 676 1 p.

Research output: Contribution to journalArticle

First-line treatment of non small cell lung cancer

Toschi, L., Finocchiaro, G. & Cappuzzo, F., Dec 2007, In : Minerva Pneumologica. 46, 4, p. 243-259 17 p.

Research output: Contribution to journalArticle

Is gemcitabine cost effective in cancer treatment?

Toschi, L., Finocchiaro, G., Ceresoli, G. L., Zucali, P. A., Cavina, R., Garassino, I., De Vincenzo, F., Santoro, A. & Cappuzzo, F., Jun 2007, In : Expert Review of Pharmacoeconomics and Outcomes Research. 7, 3, p. 239-249 11 p.

Research output: Contribution to journalArticle

Optimizing anti-EGFR strategies in cancer treatment

Toschi, L., Finocchiaro, G., Garassino, I., De Vincenzo, F., Campagnoli, E., Ceresoli, G. L., Cavina, R., Zucali, P. A., Santoro, A. & Cappuzzo, F., Nov 2007, In : Current Cancer Therapy Reviews. 3, 4, p. 267-275 9 p.

Research output: Contribution to journalArticle

Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-akt-positive or never smoker patients with advanced non-small-cell lung cancer: The ONCOBELL trial

Cappuzzo, F., Ligorio, C., Jänne, P. A., Toschi, L., Rossi, E., Trisolini, R., Paioli, D., Holmes, A. J., Magrini, E., Finocchiaro, G., Bartolini, S., Cancellieri, A., Ciardiello, F., Patelli, M., Crino, L. & Varella-Garcia, M., Jun 1 2007, In : Journal of Clinical Oncology. 25, 16, p. 2248-2255 8 p.

Research output: Contribution to journalArticle

2006

Anti-cancer therapy with EGFR inhibitors: Factors of prognostic and predictive significance

Metro, G., Finocchiaro, G. & Cappuzzo, F., Apr 2006, In : Annals of Oncology. 17, SUPPL. 2

Research output: Contribution to journalArticle

Clinical experience with gefitinib: An update

Cappuzzo, F., Finocchiaro, G., Metro, G., Bartolini, S., Magrini, E., Cancellieri, A., Trisolini, R., Castaldini, L., Tallini, G. & Crino, L., Apr 2006, In : Critical Reviews in Oncology/Hematology. 58, 1, p. 31-45 15 p.

Research output: Contribution to journalArticle

Development of gemcitabine in non-small cell lung cancer: The Italian contribution

Metro, G., Cappuzzo, G., Finocchiaro, G., Toschi, L. & Crinò, L., May 2006, In : Annals of Oncology. 17, SUPPL. 5

Research output: Contribution to journalArticle

Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC).

Metro, G., Finocchiaro, G., Toschi, L., Bartolini, S., Magrini, E., Cancellieri, A., Trisolini, R., Castaldini, L., Tallini, G., Crino, L. & Cappuzzo, F., Jan 2006, In : Reviews on Recent Clinical Trials. 1, 1, p. 1-13 13 p.

Research output: Contribution to journalArticle

Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib

Cappuzzo, F., Toschi, L., Tallini, G., Ceresoli, G. L., Domenichini, I., Bartolini, S., Finocchiaro, G., Magrini, E., Metro, G., Cancellieri, A., Trisolini, R., Crino, L., Bunn, P. A., Santoro, A., Franklin, W. A., Varella-Garcia, M. & Hirsch, F. R., Jul 2006, In : Annals of Oncology. 17, 7, p. 1120-1127 8 p.

Research output: Contribution to journalArticle

Use of molecular screening for clinical trials with EGFR inhibitors

Bartolini, S., Toschi, L., Finocchiaro, G., Metro, G. & Cappuzzo, F., Feb 2006, In : Signal. 6, 3, p. 10-14 5 p.

Research output: Contribution to journalArticle

2005

Perspectives on salvage therapy for non-small-cell lung cancer

Cappuzzo, F., Finocchiaro, G., Trisolini, R., Toschi, L., Bartolini, S., Metro, G. & Crinò, L., 2005, In : Oncology. 19, 8, p. 989-995 7 p.

Research output: Contribution to journalArticle

Role of gemcitabine in cancer therapy

Toschi, L., Finocchiaro, G., Bartolini, S., Gioia, V. & Cappuzzo, F., Feb 2005, In : Future Oncology. 1, 1, p. 7-17 11 p.

Research output: Contribution to journalArticle

Role of gemcitabine in cancer therapy.

Toschi, L., Finocchiaro, G., Bartolini, S., Gioia, V. & Cappuzzo, F., Feb 2005, In : Future Oncology. 1, 1, p. 7-17 11 p.

Research output: Contribution to journalArticle

2003

L-Carnitine in the treatment of mild or moderate hepatic encephalopathy

Malaguarnera, M., Pistone, G., Astuto, M., Dell'Arte, S., Finocchiaro, G., Lo Giudice, E. & Pennisi, G., 2003, In : Digestive Diseases. 21, 3, p. 271-275 5 p.

Research output: Contribution to journalArticle